Elon Musk's xAI has secured a controversial air permit for its Memphis AI hub, escalating a legal battle with the NAACP and ...

STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the ...

www.vicorepharma.com This information is information that Vicore Pharma Holding is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for ...

The Netzwerk Datenschutzexpertise sharply criticizes the Praxisregister Schmerz. The data is used for non-transparent, ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest ...

Build a Rocket Boy, developer of MindsEye, is entering a UK-mandated consultation for over 100 layoffs after its poorly ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment ...

As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. Tonix does not undertake an obligation to ...

EQS-News: Heidelberg Pharma AG / Key word (s): StudyHeidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma 27.05.2025 / 08:07 ...

The Centre’s Department of Pharmaceuticals is inviting applications from drugmakers for a production linked incentive (PLI) scheme to encourage setting up new manufacturing capacities for as ...